• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙酮酸激酶缺乏症的患病率:系统文献回顾。

Prevalence of pyruvate kinase deficiency: A systematic literature review.

机构信息

IQVIA Epidemiology & Drug Safety, Cambridge, MA, USA.

Agios Pharmaceuticals Inc., Cambridge, MA, USA.

出版信息

Eur J Haematol. 2020 Aug;105(2):173-184. doi: 10.1111/ejh.13424. Epub 2020 Jun 23.

DOI:10.1111/ejh.13424
PMID:32279356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7496626/
Abstract

OBJECTIVES

Pyruvate kinase deficiency (PK deficiency) is a rare disorder caused by compound heterozygosity or homozygosity for > 300 mutations in the PKLR gene. To understand PK deficiency prevalence, we conducted a systematic literature review.

METHODS

We queried Embase and Medline for peer-reviewed references reporting PK deficiency prevalence/incidence, PKLR mutant allele frequency (MAF) among the general population, or crude results from which these metrics could be derived.

RESULTS

Of 1390 references screened, 1296 were excluded after title/abstract review; 60 were excluded after full-text review. Four of the remaining 34 studies were considered high-quality for estimating PK deficiency prevalence. Two high-quality studies identified cases from source populations of known sizes, producing estimates of diagnosed PK deficiency prevalence of 3.2 and 8.5 per million. Another high-quality study derived an estimate of diagnosed PK deficiency prevalence of 6.5 per million by screening jaundiced newborns. The final high-quality study estimated total diagnosed and undiagnosed PK deficiency prevalence to be 51 per million through extrapolation from observed MAFs.

CONCLUSIONS

We conclude that prevalence of clinically diagnosed PK deficiency is likely between 3.2 and 8.5 per million in Western populations, while the prevalence of diagnosed and undiagnosed PK deficiency could possibly be as high as 51 per million.

摘要

目的

丙酮酸激酶缺乏症(PK 缺乏症)是一种由 PKLR 基因中>300 种突变的复合杂合子或纯合子引起的罕见疾病。为了了解 PK 缺乏症的患病率,我们进行了系统的文献回顾。

方法

我们在 Embase 和 Medline 上查询了同行评审的参考文献,这些参考文献报告了 PK 缺乏症的患病率/发病率、普通人群中 PKLR 突变等位基因频率(MAF)或可从中得出这些指标的原始结果。

结果

在筛选出的 1390 篇参考文献中,经过标题/摘要审查后排除了 1296 篇;经过全文审查后排除了 60 篇。其余 34 篇研究中有 4 篇被认为是估算 PK 缺乏症患病率的高质量研究。两项高质量研究从已知大小的来源人群中确定了病例,得出的诊断 PK 缺乏症患病率估计值分别为每百万 3.2 和 8.5。另一项高质量研究通过筛查黄疸新生儿得出了诊断 PK 缺乏症患病率为每百万 6.5 的估计值。最后一项高质量研究通过观察到的 MAF 外推得出总诊断和未诊断 PK 缺乏症患病率为 51 每百万。

结论

我们得出结论,在西方人群中,临床诊断的 PK 缺乏症患病率可能在每百万 3.2 至 8.5 之间,而诊断和未诊断的 PK 缺乏症患病率可能高达每百万 51。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb1/7496626/82f75e007c8c/EJH-105-173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb1/7496626/82f75e007c8c/EJH-105-173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb1/7496626/82f75e007c8c/EJH-105-173-g001.jpg

相似文献

1
Prevalence of pyruvate kinase deficiency: A systematic literature review.丙酮酸激酶缺乏症的患病率:系统文献回顾。
Eur J Haematol. 2020 Aug;105(2):173-184. doi: 10.1111/ejh.13424. Epub 2020 Jun 23.
2
Comorbidities and complications in adults with pyruvate kinase deficiency.丙酮酸激酶缺乏症成人患者的合并症和并发症
Eur J Haematol. 2021 Apr;106(4):484-492. doi: 10.1111/ejh.13572. Epub 2021 Jan 24.
3
The burden of disease in pyruvate kinase deficiency: Patients' perception of the impact on health-related quality of life.丙酮酸激酶缺乏症的疾病负担:患者对其健康相关生活质量影响的认知。
Eur J Haematol. 2018 Dec;101(6):758-765. doi: 10.1111/ejh.13128. Epub 2018 Sep 28.
4
Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene.突尼斯人丙酮酸激酶缺乏症的分子基础:PKLR基因中影响编码区和非编码区的新突变描述
Int J Lab Hematol. 2017 Apr;39(2):223-231. doi: 10.1111/ijlh.12610. Epub 2017 Jan 30.
5
A novel and a previously described compound heterozygous PKLR gene mutations causing pyruvate kinase deficiency in a Chinese child.一个导致中国儿童丙酮酸激酶缺乏症的新型和一个先前描述的复合杂合PKLR基因突变。
Fetal Pediatr Pathol. 2014 Jun;33(3):182-90. doi: 10.3109/15513815.2014.890260. Epub 2014 Mar 6.
6
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.丙酮酸激酶缺乏症的临床谱:来自丙酮酸激酶缺乏症自然史研究的数据。
Blood. 2018 May 17;131(20):2183-2192. doi: 10.1182/blood-2017-10-810796. Epub 2018 Mar 16.
7
Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease-specific assessments.丙酮酸激酶缺乏症日记和丙酮酸激酶缺乏症影响评估的制定:疾病特异性评估。
Eur J Haematol. 2020 May;104(5):427-434. doi: 10.1111/ejh.13376. Epub 2020 Feb 24.
8
Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population.根据普通白人人群中的基因频率估算丙酮酸激酶缺乏症的患病率。
Blood. 2000 Jun 1;95(11):3585-8.
9
Red blood cell PK deficiency: An update of PK-LR gene mutation database.红细胞丙酮酸激酶缺乏症:PK-LR基因突变数据库的更新
Blood Cells Mol Dis. 2016 Mar;57:100-9. doi: 10.1016/j.bcmd.2015.12.009. Epub 2016 Jan 12.
10
Identification and in silico characterization of a novel PKLR genotype in a Turkish newborn.鉴定并计算机模拟分析一名土耳其新生儿中的新型 PKLR 基因型。
Mol Biol Rep. 2020 Oct;47(10):8311-8315. doi: 10.1007/s11033-020-05836-2. Epub 2020 Sep 24.

引用本文的文献

1
Pyruvate Kinase Deficiency: Markedly Decreased Reticulocyte PK Activity and Limited Specificity of the PK/HK Ratio.丙酮酸激酶缺乏症:网织红细胞丙酮酸激酶活性显著降低以及丙酮酸激酶/己糖激酶比值的特异性有限。
Int J Mol Sci. 2025 Sep 4;26(17):8606. doi: 10.3390/ijms26178606.
2
Neonatal Hemolytic Jaundice: Causes, Diagnostic Approach, and Management.新生儿溶血性黄疸:病因、诊断方法及治疗
Children (Basel). 2025 May 23;12(6):666. doi: 10.3390/children12060666.
3
Overall Survival of Patients With Pyruvate Kinase Deficiency in the UK: A Real-World Study.

本文引用的文献

1
Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.丙酮酸激酶缺乏症的基因型-表型相关性和分子异质性。
Am J Hematol. 2020 May;95(5):472-482. doi: 10.1002/ajh.25753. Epub 2020 Mar 6.
2
Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.解决丙酮酸激酶缺乏症的诊断差距:丙酮酸激酶缺乏症诊断的共识建议。
Am J Hematol. 2019 Jan;94(1):149-161. doi: 10.1002/ajh.25325. Epub 2018 Nov 28.
3
Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067.
英国丙酮酸激酶缺乏症患者的总生存期:一项真实世界研究。
EJHaem. 2025 Mar 3;6(2):e70009. doi: 10.1002/jha2.70009. eCollection 2025 Apr.
4
Efficacy and Safety of Mitapivat in Pyruvate Kinase Deficiency: A Systematic Review and Meta-analysis of Clinical Trials.米他匹瓦特治疗丙酮酸激酶缺乏症的疗效与安全性:一项临床试验的系统评价和荟萃分析
Indian J Hematol Blood Transfus. 2025 Jan;41(1):112-120. doi: 10.1007/s12288-024-01830-x. Epub 2024 Aug 6.
5
Clinical and Demographic Characteristics of Pyruvate Kinase Deficiency Patients: A Comprehensive Case Series Analysis.丙酮酸激酶缺乏症患者的临床和人口统计学特征:一项综合病例系列分析
Cureus. 2024 May 10;16(5):e60035. doi: 10.7759/cureus.60035. eCollection 2024 May.
6
Pyruvate kinase activators for treatment of pyruvate kinase deficiency.丙酮酸激酶激活剂治疗丙酮酸激酶缺乏症。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):97-106. doi: 10.1182/hematology.2023000466.
7
Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults.米他培坦:成人丙酮酸激酶缺乏症的治疗药物。
Drugs. 2023 Nov;83(17):1613-1620. doi: 10.1007/s40265-023-01961-x. Epub 2023 Nov 22.
8
Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial.在 3 期 ACTIVATE 试验中对成年人的丙酮酸激酶缺乏症日记和丙酮酸激酶缺乏症影响评估进行心理测量学验证。
J Patient Rep Outcomes. 2023 Nov 9;7(1):112. doi: 10.1186/s41687-023-00650-3.
9
An innovative phase I study in healthy subjects to determine the mass balance, elimination, metabolism, and absolute bioavailability of mitapivat.一项创新性的健康受试者 I 期研究,旨在确定 mitapivat 的物质平衡、消除、代谢和绝对生物利用度。
Clin Transl Sci. 2023 Oct;16(10):2021-2032. doi: 10.1111/cts.13609. Epub 2023 Aug 18.
10
Treating pyruvate kinase deficiency with Mitapivat: a short communication.用米塔匹瓦特治疗丙酮酸激酶缺乏症:一篇简短通讯
Ann Med Surg (Lond). 2023 May 3;85(6):3241-3242. doi: 10.1097/MS9.0000000000000759. eCollection 2023 Jun.
在美国、泰国和南非人群中发现激活替诺福韦的激酶的遗传变异体:HPTN067。
PLoS One. 2018 Apr 11;13(4):e0195764. doi: 10.1371/journal.pone.0195764. eCollection 2018.
4
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.丙酮酸激酶缺乏症的临床谱:来自丙酮酸激酶缺乏症自然史研究的数据。
Blood. 2018 May 17;131(20):2183-2192. doi: 10.1182/blood-2017-10-810796. Epub 2018 Mar 16.
5
Novel mutations associated with pyruvate kinase deficiency in Brazil.巴西与丙酮酸激酶缺乏症相关的新型突变
Hematol Transfus Cell Ther. 2018 Jan-Mar;40(1):5-11. doi: 10.1016/j.bjhh.2017.08.007. Epub 2017 Nov 26.
6
Newborn Screening for Hemoglobinopathies and Red Cell Enzymopathies in Tripura State: A Malaria-Endemic State in Northeast India.印度东北部疟疾流行邦特里普拉邦血红蛋白病和红细胞酶病的新生儿筛查
Hemoglobin. 2018 Jan;42(1):43-46. doi: 10.1080/03630269.2018.1428619. Epub 2018 Feb 8.
7
Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits.外显子基因分型鉴定出与红细胞性状相关的多效性变异。
Am J Hum Genet. 2016 Jul 7;99(1):8-21. doi: 10.1016/j.ajhg.2016.05.007. Epub 2016 Jun 23.
8
Erythrocyte pyruvate kinase deficiency: 2015 status report.红细胞丙酮酸激酶缺乏症:2015年现状报告。
Am J Hematol. 2015 Sep;90(9):825-30. doi: 10.1002/ajh.24088. Epub 2015 Aug 14.
9
Pyruvate kinase deficiency in sub-Saharan Africa: identification of a highly frequent missense mutation (G829A;Glu277Lys) and association with malaria.撒哈拉以南非洲的丙酮酸激酶缺乏症:高度频繁的错义突变(G829A;Glu277Lys)的鉴定及其与疟疾的关联。
PLoS One. 2012;7(10):e47071. doi: 10.1371/journal.pone.0047071. Epub 2012 Oct 17.
10
Genetic diversity in human erythrocyte pyruvate kinase.人类红细胞丙酮酸激酶的遗传多样性。
Genes Immun. 2012 Jan;13(1):98-102. doi: 10.1038/gene.2011.54. Epub 2011 Aug 11.